Research programme: diferuloylmethane analogues - IntraBio
Alternative Names: IB 2000; IB2000 seriesLatest Information Update: 13 Jan 2023
At a glance
- Originator IntraBio
- Class Small molecules; Vestibular disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Meniere's disease
Most Recent Events
- 29 Nov 2022 Clinical trial in Meniere's disease in United Kingdom (unspecified route), before November 2022 (IntraBio pipeline, November 2022)